PHASE III RANDOMIZED STUDY OF ENZASTAURIN/R‐CHOP VS PLACEBO/R‐CHOP IN FRONTLINE HIGH RISK DIFFUSE LARGE B CELL LYMPHOMA PATIENTS WITH GENOMIC BIOMARKER DGM1 (ENGINE STUDY)
Sign Up to like & getrecommendations! Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.37_2629
Abstract: Karyopharm Therapeutics, Kite Pharma, Lundbeck, Merck, Roche/Genentech, Inc., Seattle Genetics, Takeda, Teva, TG Therapeutics; Research Funding: Roche/Genentech, Inc. Sharman, J: Consultant Advisory Role: Pharmacyclics, Celgene, TG Therapeutics, Genentech, Inc., AbbVie, Acerta Pharma/AstraZeneca; Research Funding: Pharmacyclics,… read more here.
Keywords: gilead sciences; study; genentech inc; oncology ... See more keywords
West African Crystalline Maculopathy in a Nigerian Woman.
Sign Up to like & getrecommendations! Published in 2018 at "Ophthalmology"
DOI: 10.1016/j.ophtha.2017.11.022
Abstract: Originally received: March 28, 2017. Final revision: July 21, 2017. Accepted: August 30, 2017. Available online: October 27, 2017. Manuscript no. 2017-714. 1 Department of Ophthalmology, University of Bonn, Bonn, Germany. 2 Department of Ophthalmology… read more here.
Keywords: new york; roche; ophthalmology; genentech inc ... See more keywords
AB0448 Patient-reported outcomes following discontinuation of methotrexate in patients with rheumatoid arthritis treated with subcutaneous tocilizumab: results from a randomised controlled trial
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.1838
Abstract: Background Patients with rheumatoid arthritis (RA) often receive methotrexate (MTX) in combination with biologics; however, MTX may be discontinued due to intolerance or to reduce the medication burden once disease control is achieved. Whereas previous… read more here.
Keywords: genentech inc; week; mtx; tcz mtx ... See more keywords
Geriatric Assessment (GA) Measures and Patient-Reported Outcomes (PROs) Among Older Adults Treated in a Phase 1b Study for Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-116038
Abstract: Introduction The measurement, analysis, and communication of treatment-related symptoms and their impact on the functioning of individuals in clinical trials is an area of interest to the medical community, the Food and Drug Administration and… read more here.
Keywords: phase; treatment; gas; genentech inc ... See more keywords
86-OR: Primary Results from Two Phase 3 Trials of Faricimab for Diabetic Macular Edema (DME): YOSEMITE and RHINE
Sign Up to like & getrecommendations! Published in 2021 at "Diabetes"
DOI: 10.2337/db21-86-or
Abstract: The leading cause of vision loss in people with diabetic retinopathy (DR) is DME. Intravitreal anti-VEGF therapy is the standard of care for DME; however, optimal vision outcomes are difficult to achieve, and the need… read more here.
Keywords: employee; self genentech; roche pharma; dme ... See more keywords
111-OR: Assessing the Diabetic Eye Disease Care Continuum—Screening Gaps and Predictors among Type 2 Diabetes Mellitus Patients at Two Academic Medical Centers within the University of California Health System
Sign Up to like & getrecommendations! Published in 2025 at "Diabetes"
DOI: 10.2337/db25-111-or
Abstract: Introduction and Objective: The American Diabetes Association recommends annual eye exams for adults with Diabetes Mellitus Type 2 (T2DM); however, barriers to timely screening persist. This study assesses the diabetic eye care continuum among patients… read more here.
Keywords: research support; inc; eye; genentech inc ... See more keywords